Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Raw Materials (2023 - 2024)

Historic Raw Materials for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Q4 2024 value amounting to $1.0 million.

  • Zhengye Biotechnology Holding's Raw Materials fell 2453.83% to $1.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.0 million, marking a year-over-year decrease of 2453.83%. This contributed to the annual value of $1.0 million for FY2024, which is 2702.38% down from last year.
  • Zhengye Biotechnology Holding's Raw Materials amounted to $1.0 million in Q4 2024, which was down 2453.83% from $1.4 million recorded in Q4 2023.
  • In the past 5 years, Zhengye Biotechnology Holding's Raw Materials registered a high of $1.4 million during Q4 2023, and its lowest value of $1.0 million during Q4 2024.